Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00487006 · ClinicalTrials.gov registry record · NA
Study of High Blood Sugars and Insulin in Hospitalized, Critically Ill Children
A NA study, sponsored by Children's Healthcare of Atlanta.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT00487006 is a NA study that has completed, run by Children's Healthcare of Atlanta. The registered enrollment target is 209 participants.
The verdict
NCT00487006, a NA study, has completed, sponsored by Children's Healthcare of Atlanta.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
BACKGROUND AND PURPOSE Critical illness hyperglycemia (CIH) - elevated blood glucose in the critically ill patient population - has gained much interest among health care providers over the past several years. Clinical studies in adults have documented a high rate of hyperglycemia in some post-surgical and medical intensive care units (ICUs). However, the primary reasons for interest in this topic are not due just to its high rate, but also to the fact that by returning the high glucose levels found in this population to normal with insulin therapy can dramatically improve clinical outcomes by decreasing both morbidity and long-term mortality. Because of this, aggressive glucose control has become common practice in adult ICU critical care management. Although there is substantial data describing the high incidence of CIH in adult patients, there is little information regarding this condition in children. A single retrospective study recently published also suggested a high incidence of CIH in children with critical illness secondary to both medical and surgical causes. It is yet to be determined if, like in adults, normalizing blood glucose levels with insulin improves outcomes in this pediatric population. Because evidence appears compelling that hyperglycemia is both common and detrimental in adults, many pediatric ICUs have likewise begun to focus on aggressively treating hyperglycemia in critically ill children. The proposed study is a prospective observational pilot study to occur in the Pediatric Intensive Care Unit (PICU) at Children's Healthcare of Atlanta at Egleston. This prospective pilot study is being done to evaluate the endocrine factors associated with, if not responsible for, CIH, and the changes that take place with the restoration of normal blood glucose levels by insulin therapy. To address these profound issues this study will pursue two interrelated Aims: Aim #1: To determine if critical illness hyperglycemia is associated with absolute i
Interventions
- OTHER Serum Lab testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2006-10 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00487006
The ClinicalTrials.gov registry entry for NCT00487006 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Serum Lab testing is the first listed.
NCT00487006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00487006 about?
NCT00487006 is a clinical study titled "Study of High Blood Sugars and Insulin in Hospitalized, Critically Ill Children". BACKGROUND AND PURPOSE Critical illness hyperglycemia (CIH) - elevated blood glucose in the critically ill patient population - has gained much interest among health care providers over the past several years. Clinical studies in adults have documented a high rate of hyperglycemia in some post-surg...
What is the current status of trial NCT00487006?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2006-10. Estimated completion is 2015-02.
What interventions are being tested in trial NCT00487006?
The interventions under investigation include: Serum Lab testing (OTHER).
Who is sponsoring clinical trial NCT00487006?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.